Identification of binding sites for C‐terminal pro‐gastrin‐releasing peptide (GRP)‐derived peptides in renal cell carcinoma: a potential target for future therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|115|5|829-838

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.115, Iss.5, 2015-05, pp. : 829-838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Demonstration and Diagnostic Significance of Pro-Gastrin-Releasing Peptide in Medullary Thyroid Carcinoma

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 122-125

Karger

Access to resources Recommend Favorite

Serum Pro-Gastrin-Releasing Peptide Is a Useful Marker for Treatment Monitoring and Survival in Small-Cell Lung Cancer

By  

Oncology, Vol. 57, Iss. 2, 1999-08 ,pp. : 143-148

Karger

Access to resources Recommend Favorite

C-Terminal Heparin-Binding Peptide of Snake Venom VEGF Specifically Blocks VEGF-Stimulated Endothelial Cell Proliferation

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 4-5, 2006-05 ,pp. : 197-199

Karger

Access to resources Recommend Favorite

The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders

By  

Recent Patents on CNS Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor 1 as a Target for the Therapy of Renal Cell Carcinoma

By  

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 321-331

Karger

Access to resources Recommend Favorite